Table 4.
Formulation | Manufacturer | Disease indications |
---|---|---|
PEG-anti-TNFα antibody fragment | Nektar | Crohn's desease, Rheumatoid arthritis |
Rhenium-labeled doxorubicin | Azaya Therapeutics | Metastatic breast cancer |
Methotrexate-folic acid Ployamidomine (PAMAM) dendrimers | Michigan Nanotechnology Institute, University of Michigan | Epithelial cancers |
PEGylated hyaluronidase | Halozyme Therapeutics | Solid tumors |
Prostate specific membrane antigen (PSMA) dendrimers | BIND Biosciences | Prostate cancer |
Transferrin-diphtheria toxin conjugate | Xenova (KS Biomedix) | High-grade glioma |